COVID-19News

KAISHA Packaging achieves feat for supplying seals for 2 bn doses of COVID vaccines globally 

The company has expanded its capacity by over 450 million pieces to reach the overall capacity of 1.2 billion pieces per annum over the past year

Leading pharma-packaging firm, KAISHA Packaging has accomplished new heights in the fight against COVID-19. The company has successfully provided over 2 billion doses worth of flip-top aluminium seals used for packaging covid vaccines. The seal is used as a closure for injection vials during the vaccination drive and is as such an essential part of the vaccine package ensuring tamper-proof delivery. This is especially relevant for fulfilling India and the world’s current vaccination drive, especially given the need for successive booster doses considering the ever-changing nature of COVID. 

KAISHA Packaging has been a constant and biggest supplier for these seals to all the vaccines available in the Indian market and abroad. To ensure a consistent supply of vaccines and plug any shortages or gaps, the company managed to arrange and stock an extremely large volume of raw material. Not only did KAISHA Packaging successfully manage this challenge it also expanded its capacity by over 450 million pieces to reach the overall capacity of 1.2 billion pieces per annum over the past year, which was unprecedented. 

Rishad Dadachanji, Director, KAISHA Group of Companies, shared, “This is a testimonial of our commitment to support India’s vaccine drive and developers with the best packaging solutions. As a pharma allied sector company, we have worked hard to ensure no gaps remain in our supply chain to ensure a consistent supply of vaccine seals. We are proud to have provided seals for over 2 billion vaccine doses so far. Under the current circumstances of ambiguity around the COVID pandemic, Kaisha is well-prepared to rise up to any supply challenges.” 

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Leave a Reply

Back to top button
Close
Close